FindTrial
Sign In

Effect of dhanyamla parisheka in rheumatoid arthritis

A Clinical study to evaluate the effect of dhanyamla parisheka in rheumatoid arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032830
Enrollment
30
Registered
2021-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M049- Autoinflammatory syndrome, unspecified

Interventions

Intervention1: Dhanyamla parisheka: Dhanyamla parisheka done in patients as per procedure for 7 days. Control Intervention1: NIL: NIL

Sponsors

Dr Athreya sharma M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of rheumatoid arthritis

Exclusion criteria

Exclusion criteria: Patients with systemic illnesses All connective tissue disorders other than rheumatoid arthritis

Design outcomes

Primary

MeasureTime frame
Reduction in pain , stiffness and swelling in rheumatoid arthritisTimepoint: 7days—

Secondary

MeasureTime frame
Symptomatic relief in symptoms of rheumatoid arthritis facilitate withdrawal from corticosteroid course of treatmentTimepoint: 14 days—

Countries

India

Contacts

Public ContactDr Athreya Sharma M

Sri Dharmasthala Manjunatheshwara college of ayurveda kuthpady,udupi

rao.drniranjan@gmail.com9448835203

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026